Eprazinone
Star0
Identification
- Generic Name
- Eprazinone
- DrugBank Accession Number
- DB08990
- Background
Eprazinone (trade name Eftapan) is a mucolytic drug, and relieves bronchospasms.
- Type
- Small Molecule
- Groups
- Experimental, Withdrawn
- Structure
- Weight
- Average: 380.532
Monoisotopic: 380.246378278 - Chemical Formula
- C24H32N2O2
- Synonyms
- eprazinona
- Eprazinone
- Éprazinone
- External IDs
- CE 746
- CG-B 6 K
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Eprazinone Hydrochloride 394X1L8I9Y 10402-53-6 BPMQVOKMMQFZGV-UHFFFAOYSA-N
Categories
- ATC Codes
- R05CB04 — Eprazinone
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Carbonyl compounds
- Direct Parent
- Alkyl-phenylketones
- Alternative Parents
- Phenylpropanes / Benzylethers / Benzoyl derivatives / Aryl alkyl ketones / N-alkylpiperazines / Aralkylamines / Beta-amino ketones / Trialkylamines / Dialkyl ethers / Azacyclic compounds show 3 more
- Substituents
- 1,4-diazinane / Alkyl-phenylketone / Amine / Aralkylamine / Aromatic heteromonocyclic compound / Aryl alkyl ketone / Azacycle / Benzenoid / Benzoyl / Benzylether show 15 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- ether, N-alkylpiperazine, aromatic ketone (CHEBI:82716)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 883YNL63WU
- CAS number
- 10402-90-1
- InChI Key
- BSHWLCACYCVCJE-UHFFFAOYSA-N
- InChI
- InChI=1S/C24H32N2O2/c1-3-28-23(21-10-6-4-7-11-21)19-26-16-14-25(15-17-26)18-20(2)24(27)22-12-8-5-9-13-22/h4-13,20,23H,3,14-19H2,1-2H3
- IUPAC Name
- 3-[4-(2-ethoxy-2-phenylethyl)piperazin-1-yl]-2-methyl-1-phenylpropan-1-one
- SMILES
- CCOC(CN1CCN(CC(C)C(=O)C2=CC=CC=C2)CC1)C1=CC=CC=C1
References
- Synthesis Reference
U.S. Patent 3,448,192.
- General References
- Not Available
- External Links
- KEGG Drug
- D07902
- PubChem Compound
- 3245
- PubChem Substance
- 310264951
- ChemSpider
- 3132
- 24272
- ChEBI
- 82716
- ChEMBL
- CHEMBL1885437
- Drugs.com
- Drugs.com Drug Page
- Wikipedia
- Eprazinone
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 160 U.S. Patent 3,448,192. - Predicted Properties
Property Value Source Water Solubility 0.0484 mg/mL ALOGPS logP 3.78 ALOGPS logP 4.14 Chemaxon logS -3.9 ALOGPS pKa (Strongest Acidic) 16.21 Chemaxon pKa (Strongest Basic) 7.32 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 32.78 Å2 Chemaxon Rotatable Bond Count 9 Chemaxon Refractivity 115.29 m3·mol-1 Chemaxon Polarizability 44.38 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-001i-0009000000-424c6de991a653bef01d Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-002r-1389000000-e40a89778d15a2c25a84 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-053r-0926000000-692b8a9eabfbf0659300 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-004i-1693000000-8b1d01faea15b1a8b949 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4r-3922000000-87db13ed4962bc019afe Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-01z9-2593000000-e8f2e9a816fa755f277e Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 190.62523 predictedDeepCCS 1.0 (2019) [M+H]+ 193.15773 predictedDeepCCS 1.0 (2019) [M+Na]+ 201.76482 predictedDeepCCS 1.0 (2019)
Drug created at June 10, 2014 22:52 / Updated at December 02, 2023 07:01